Impact Factor
3.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.42
5,591 total citations
h5-index
68
h5 depth signal
Cited share
62.9%
1,066 of 1,695
Total citations
5,591
Citation footprint
Metric signal
3.38
External metric anchor
Self-citation
5.2%
288 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
1,437
Italy
1,320
France
1,232
United States
1,177
Spain
768
Citing Fields of Research
Dermatology
4,587
Allergies
1,755
Musculoskeletal Disorders
898
Oncology
730
Auto-Inflammatory Disorders
673
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
19,153
Articles tracked across the journal lifetime
Indexed publication set
1,695
1,066 cited publications
Last 12 months
693
57.8 publications/month
Open access share
27.4%
190 OA publications in the last year
Leading citing country
Germany
1,437 citing publications
Leading citing field
Dermatology
4,587 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v10n1,Jan. 1998-
v10n1,Jan. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Dermatology
Allergies
Musculoskeletal Disorders
Oncology
Issuing & Sponsoring Bodies
Contributor
European Academy of Dermatology and Venereology
Broad Categories
Dermatology
Sexually Transmitted Diseases
Allergies
Musculoskeletal Disorders
MeSH Descriptors
Sexually Transmitted Diseases
Skin Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1111/jdv.70818
Open DOI
Cutaneous manifestations of VEXAS syndrome in a tertiary centre cohort
03
04
DOI 10.1111/jdv.70763
Open DOI
Female genital lichen sclerosus
Female genital lichen sclerosus (FGLSc) is a chronic inflammatory scarring dermatosis that can lead to scarring and irreversible architectural change, sexual and urological dysfunction and malignancy. Although the aetiology is not comple...
05
DOI 10.1111/jdv.70807
Open DOI
Real‐world comparison of sonidegib and vismodegib in advanced basal cell carcinoma
06
DOI 10.1111/jdv.70806
Open DOI
Efficacy and safety of therapies for Grover disease: A systematic review
07
DOI 10.1111/jdv.70790
Open DOI
Experience‐based recommendations for the diagnosis and management of early‐stage nail unit melanoma
Background: Nail unit melanoma (NUM) is a distinct form of melanoma that most often arises from the nail matrix. No recommendations as to the management of nail melanoma, particularly of early‐stage melanoma (in situ, stage IA, IB), exis...
08
DOI 10.1111/jdv.70787
Open DOI
Optimizing therapy in hidradenitis suppurativa: Combination, sequencing and treat‐to‐target
Hidradenitis suppurativa (HS) is a chronic, recurrent and progressively destructive inflammatory disease associated with substantial physical, psychological and social burden. The therapeutic landscape of HS has rapidly evolved with the ...
09
10
Bibliographical & Catalog Notes
Also issued online.
Vol. 1, no. 1 (1992)19981002 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper